Abstract
Mutations in subunits of the mitochondrial NADH dehydrogenase cause mitochondrial complex I deficiency, a group of severe neurological diseases that can result in death in infancy. The pathogenesis of complex I deficiency remain poorly understood, and as a result there are currently no available treatments. To better understand the underlying mechanisms, we modelled complex I deficiency in Drosophila using knockdown of the mitochondrial complex I subunit ND-75 (NDUFS1) specifically in neurons. Neuronal complex I deficiency causes locomotor defects, seizures and reduced lifespan. At the cellular level, complex I deficiency does not affect ATP levels but leads to mitochondrial morphology defects, reduced endoplasmic reticulum-mitochondria contacts and activation of the endoplasmic reticulum unfolded protein response (UPR) in neurons. Multi-omic analysis shows that complex I deficiency dramatically perturbs mitochondrial metabolism in the brain. We find that expression of the yeast non-proton translocating NADH dehydrogenase NDI1, which reinstates mitochondrial NADH oxidation but not ATP production, restores levels of several key metabolites in the brain in complex I deficiency. Remarkably, NDI1 expression also reinstates endoplasmic reticulum-mitochondria contacts, prevents UPR activation and rescues the behavioural and lifespan phenotypes caused by complex I deficiency. Together, these data show that metabolic disruption due to loss of neuronal NADH dehydrogenase activity cause UPR activation and drive pathogenesis in complex I deficiency.
Author summary
Mutations in the mitochondrial NADH dehydrogenase cause complex I deficiency, a mitochondrial disease characterised by severe neurological problems and death in the first years of life. To understand the underlying mechanisms, we modelled complex I deficiency in the fruit fly Drosophila. Flies with complex I deficiency in neurons have problems with movement, seizures and severely reduced lifespan. Complex I deficiency in Drosophila neurons causes altered mitochondrial morphology and reduced contacts between the mitochondria and endoplasmic reticulum but does not affect ATP levels. Moreover, a stress signalling pathway called the unfolded protein response (UPR) is activated in complex I deficient neurons. Complex I deficiency also alters metabolism in the brain. Remarkably, restoring the NADH dehydrogenase activity but not the proton pumping ability of complex I in neurons, by expressing the yeast NDI1 enzyme, restores mitochondrial morphology, prevents UPR activation and rescues the behavioural and lifespan phenotypes in complex I deficient flies. Our data suggest that metabolic disruption due to loss of neuronal NADH dehydrogenase activity drive pathogenesis in complex I deficiency.
Introduction
Mitochondrial NADH dehydrogenase-ubiquinone oxidoreductase (complex I) plays essential roles in oxidative phosphorylation (OXPHOS), NADH oxidation and reactive oxygen species (ROS) generation. Mutations in complex I subunits cause complex I deficiency, a clinically heterogenous disorder that frequently results in severe neurological symptoms and death in infancy [1]. Mutations in the complex I genes NDUFS4 and NDUFS1 commonly lead to Leigh syndrome, an aggressive form of complex I deficiency [2]. In mice, knockout of Ndufs4 specifically in the brain recapitulates the severe motor, seizure, neuroinflammatory and lifespan phenotypes associated with Leigh syndrome [3], indicating that symptoms are driven by loss of complex I activity in the nervous system.
Perturbed mitochondrial function triggers mitochondrial stress signalling pathways. Mitochondrial stress signalling enables mitochondria to communicate with the nucleus and reprogram nuclear gene expression [4–6]. Mitochondrial stress signalling can act through different mechanisms, depending on the context. In higher eukaryotes, a common target of mitochondrial stress signalling is activating transcription factor 4 (ATF4) [7–9]. ATF4 can be activated downstream of the endoplasmic reticulum unfolded protein response (UPR), or the integrated stress response (ISR). Importantly, targeting stress signalling pathways, including the UPR and ISR, has shown therapeutic potential in animal models [10,11].
Animal models of mitochondrial disease have provided valuable insights into disease mechanisms. Mouse and Drosophila complex I deficiency models have replicated several aspects of the human disease [3,12–16]. However, animal models have not previously been exploited to examine mitochondrial stress signalling in complex I deficiency. Here we interrogate a new neuron-specific Drosophila model of mitochondrial complex I deficiency. Knockdown of the complex I subunit ND-75 (NDUFS1) in neurons causes neurological phenotypes including climbing and locomotor defects, seizures and greatly reduced lifespan. ND-75 knockdown in neurons does not affect ATP levels but perturbs mitochondrial morphology, causes reduced endoplasmic reticulum (ER)-mitochondria contacts and triggers the UPR, including activation of ATF4. Loss of ND-75 also alters cellular metabolism and perturbs the TCA cycle. Expression of the single subunit yeast NADH dehydrogenase NDI1 in neurons, which facilitates the TCA cycle, rescues the aberrant mitochondrial morphology and loss of ER-mitochondria contacts resulting from ND-75 knockdown. UPR activation and ATF4 expression are also prevented by NDI1 expression. Moreover, NDI1 almost completely rescues the severe behavioural and lifespan phenotypes caused by ND-75 knockdown. Metabolomic analysis shows that NDI1 expression reverses the changes in specific metabolites caused by ND-75 knockdown, including increased levels of the neurotransmitter GABA. Collectively, this study provides novel insight into the mechanisms underlying the neurological manifestations of mitochondrial complex I deficiency.
Results
Knockdown of ND-75 in Drosophila neurons models mitochondrial complex I deficiency
Mutations in NDUFS1 cause complex I deficiency and Leigh syndrome [2,17]. Complex I initiates the electron transport chain, accepting electrons from NADH which then pass through the complex to ubiquinone. The subunits that form complex I are grouped into 3 modules: N, P and Q. NDUFS1 is an [Fe-S] cluster containing subunit involved in electron transfer that lies within the N module of the complex [18]. To model complex I deficiency in Drosophila we used a previously validated short hairpin RNAi (HMS00853) targeting the Drosophila NDUFS1 homolog ND-75 [19]. We confirmed that ND-75 knockdown (hereafter referred to as ND-75KD) ubiquitously in adult flies using the GeneSwitch system [20] strongly reduced ND-75 mRNA expression and caused an ~87% reduction in mitochondrial NADH dehydrogenase activity (S1A and S1B Fig). The ND-75 RNAi alone caused a significant reduction in ND-75 expression indicating leaking expression of the transgene (S1A Fig). Ubiquitous ND-75KD also significantly reduced the expression of ND-30 (S1C–S1E Fig), the orthologue of mammalian NDUFS3 and a component of Q module of complex I [21], suggesting collapse of the whole complex, and mirroring what has previously been observed with ND-75KD in Drosophila muscle [21].
Motor impairments are frequently reported in complex I deficiency patients [22]. Pan-neuronal ND-75KD using nSyb-GAL4 caused late pupal lethality, but dampening GAL4 activity by combining nSyb-GAL4 with Tub-Gal80ts at 25°C resulted in viable adult flies that were almost completely unable to climb (Fig 1A). Similar results were obtained with an independent non-overlapping ND-75 short hairpin RNAi (HMS00854) (S1H Fig). Although the ND-75 RNAi was leaky and caused reduced ND-75 expression this had no effect on climbing ability, whereas ubiquitous ND-75KD caused a strong reduction in climbing ability (S1A, S1F, and S1G Fig).
Fig 1. ND-75KD flies have reduced mobility, seizures and decreased lifespan.
(A) ND-75KD flies are almost completely unable to climb. Control n = 15, ND-75KD n = 15 flies. (B-D) In an 135 min open field assay, ND-75KD flies have reduced average speed (B), move a shorter total distance (C) and spend more time immobile (D) Control n = 11, ND-75KD n = 11 flies. (E) Example open field track plot of control and ND-75KD flies. (F, G) ND-75KD flies have more seizures than controls (F), which last up 4–5 mins in some cases (G) Control n = 8, ND-75KD n = 30 flies. (H) Food consumption over 24 hours is reduced in ND-75KD flies. Control n = 8, ND-75KD n = 6 feeding assay containers. (I) Lifespan is greatly reduced in ND-75KD flies. ND-75 RNAi expressed using Tub-Gal80ts; nSyb-Gal4. Controls are Tub-Gal80ts; nSyb-Gal4 hemizygotes. Control n = 92, ND-75KD n = 78. 1 day old male flies were used in (A)-(E), 1 day old males and females were used in (F)-(H). Males flies were used in (I). Data are represented as mean ± SEM and were analysed using the Student’s unpaired t test, Chi-squared for seizure frequency, or log-rank test for survival curve. ***p < 0.001. ****p < 0.0001.
To further analyse this locomotor phenotype we next measured open-field behaviour in pan-neuronal ND-75KD flies. The average speed and total distance moved by ND-75KD flies was dramatically reduced, and immobility was increased compared to control flies (Fig 1B–1E). Together, these data demonstrate that ND-75KD flies have severe motor dysfunction.
Alongside motor impairments, seizures are a common symptom of complex I deficiency [23,24]. Using a mechanical stress-induced seizure assay we found that pan-neuronal ND-75KD flies had a dramatic seizure phenotype, with 94% of flies developing seizures, which were significantly longer than controls and, in some cases, lasting four to five minutes (Fig 1F and 1G). Feeding problems are also common in complex I defiency patients [17] and we found that food intake was significantly reduced in ND-75KD flies (Fig 1H). Together with severe neurological symptoms, complex I deficiency patients typically die within the first few years of life [17,25]. Consistent with this, pan-neuronal ND-75KD flies had dramatically reduced lifespan, with a median survival of five days, compared to 48 days for controls (Fig 1I). Overall, these data show that neuronal-specific loss of ND-75 in Drosophila models the severe neurological manifestations of complex I deficiency.
ND-75KD causes reduced neuronal ER-mitochondrial contacts
Mitochondria in fibroblasts isolated from patients with complex I deficiency are fragmented and have significantly altered morphology [26,27]. We therefore investigated the effect of complex I deficiency on mitochondrial morphology in neurons. Using super-resolution microscopy, we found that ND-75KD in larval motor neurons led to striking alterations to the normal reticular mitochondrial morphology a 76% increase in mitochondrial number and a significant increase in mitochondrial volume (Fig 2A–2D). At the ultrastructural level, neuronal ND-75KD did not obviously perturb mitochondrial cristae morphology in larval neurons or the adult brain (Figs 2H, 2I, 6G, and 6I).
Fig 2. ND-75KD in larval neurons causes aberrant mitochondrial morphology and reduced ER-mitochondria contacts.
(A, B) Expression of mitochondria-targeted GFP (mitoGFP) to visualise mitochondria in control (A) or ND-75 knockdown (B) larval motor neurons using OK371-Gal4. Images were taken using iSIM. (C, D) Quantification of mitochondrial number and volume in larval motor neurons with ND-75 knockdown using OK371-Gal4. Control n = 30, ND-75KD n = 30 ROIs (E, F) Visualisation of ER-mitochondria contacts by split-GFP-based contact site sensor (SPLICS) expression in control (E) or ND-75 knockdown (F) larval motor neurons using OK371-Gal4. (G) Quantification of SPLICS puncta. Control n = 20, ND-75KD n = 18 neuromeres (H, I) Transmission electron microscopy images of mitochondria in larval CNS tissue from control or with pan-neuronal ND-75 knockdown (using nSyb-Gal4). Arrowheads indicate ER-mitochondria contacts. (J) Quantification of ER-mitochondria contacts. Control n = 25, ND-75KD n = 37 mitochondria. Controls are OK371-Gal4 or nSyb-Gal4 hemizygotes. Data are represented as mean ± SEM and were analysed using the Student’s unpaired t test. **p<0.01, ***p < 0.001, ****p < 0.0001.
Fig 6. NDI1 expression reverses the mitochondrial defects and prevents UPR activation in ND-75KD neurons.
(A-D) Mitochondria-targeted GFP (MitoGFP) expression in control (A), NDI1 expression (B), ND-75KD (C), or ND-75KD with NDI1 (D) larval motor neurons using OK371-Gal4. Images taken using iSIM. (E) Quantification of mitochondrial number. n = 30 ROIs for all genotypes. (F) Quantification of mitochondrial volume. n = 30 ROIs for all genotypes. (G-J) Transmission electron microscopy images of mitochondria in adult brain tissue from control (G), or pan-neuronal NDI1 expression (H), ND-75KD (I), or ND-75KD with NDI1 (J) using Tub-Gal80ts; nSyb-Gal4. Arrowheads indicate ER-mitochondria contacts. (K) Quantification of ER-mitochondria contacts. Control n = 44, NDI1 n = 48, n = ND-75KD n = 35, ND-75KD with NDI1 n = 34 mitochondria. 2 day old male and female flies were used. (L-O) ATF4 expression (red) in control (L), NDI1 expression (M), ND-75KD (N), or ND-75KD with NDI1 (O) larval motor neurons using OK371-Gal4. CD8-GFP expression (green) labels motor neurons. (P) Quantification of ATF4 expression. ANOVA with Tukey’s posthoc test. n = 17 larval CNS for all genotypes. Controls are OK371-Gal4 or Tub-Gal80ts; nSyb-Gal4 hemizygotes. Data are represented as mean ± SEM. n.s. not significant, *p<0.05, **p<0.01, ***p < 0.001, ***p < 0.0001.
To determine the effect of ND-75 loss on ATP synthesis, we used the Förster resonance energy transfer (FRET)–based ATP biosensor AT-NL [28], which we previously validated [29]. In neurons, as expected, AT-NL produced a significantly higher FRET signal than the AT-RK control probe that does not sense ATP (S2A–S2C Fig). ND-75KD did not alter the AT-NL probe FRET signal in neurons (S2D–S2F Fig), indicating that loss of ND-75 does not affect ATP levels in neurons. Similarly, whole heads from flies with pan-neuronal ND-75KD did not show any change in ATP levels (S2G Fig).
Changes to mitochondrial morphology lead to alterations in ER-mitochondria contacts [30,31]. Depending on the cell-type, it is estimated that ~5–35% of the mitochondrial network surface is in close proximity to the ER [32,33]. At sites of contact, mitochondria and the ER physically interact through the formation of tethering complexes [34]. ER-mitochondria contacts play vital roles in processes including Ca2+ homeostasis, mitochondrial fission, autophagy and lipid transfer. In neurons, disturbance of these contacts is strongly associated with altered cellular signalling and disease [35,36]. Therefore, we next assessed whether ER-mitochondria contacts are affected in ND-75KD neurons. To do this, we generated flies expressing the split-GFP-based contact site sensor (SPLICS) [31]. SPLICS consists of an ER membrane-bound moiety and a mitochondrial membrane-bound moiety, which reconstitute to form a functional GFP protein when the ER and mitochondria are close enough (8–50 nm) to establish contacts. Mitochondrial morphological changes that alter ER-mitochondrial contacts are detected by SPLICS probes [30,31]. In neuronal cell bodies our SPLICS probe localised to puncta that were significantly reduced by knockdown of the ER-mitochondria tethering protein IP3R [37], validating this tool (S3A–S3C Fig). ND-75KD in larval motor neurons caused a significant reduction in the number of SPLICS puncta (Fig 2E–2G), suggesting reduced ER-mitochondria connectivity. We confirmed this finding in the larval nervous system at the ultrastructural level using transmission electron microscopy (Figs 2H–2J,). These data suggest that the dramatic alteration in mitochondrial morphology resulting from ND-75 knockdown significantly reduces ER-mitochondria contacts.
The UPR is activated in ND-75KD flies
Disruption of ER-mitochondria contacts has detrimental consequences for ER function, triggering ER stress and activation of the unfolded protein response (UPR), a stress signalling pathway [38,39]. Furthermore, the UPR contributes to disease progression in animal models of neurodegenerative disease [11]. To investigate whether the UPR is activated in ND-75KD flies, we analysed expression of the UPR transcription factor ATF4. ATF4 is not normally expressed in the Drosophila brain but ND-75KD in neurons caused strong activation of ATF4 expression in the larval CNS and in the adult brain (Fig 3A, 3B, 3E and 3F). Induction of the UPR activates protein kinase R-like endoplasmic reticulum kinase (PERK), resulting in ATF4 up-regulation through the phosphorylation of the translation initiation factor eIF2α [39]. Consistent with this, ND-75KD increased phosphorylated eIF2α levels in neurons, and knockdown of PERK abrogated ATF4 activation by ND-75KD (Fig 3C, 3D and 3G–2J). Therefore, complex I deficiency activates ATF4 via the UPR in neurons.
Fig 3. ND-75KD in larval and adult neurons activates the UPR.
(A-D) ATF4 (red) expression in control (A) or ND-75KD (B), PERK knockdown (C), or ND-75KD with PERK knockdown (D) larval motor neurons using OK371-Gal4. CD8-GFP (green) expression labels motor neurons. (E, F) ATF4 expression in control (E) or pan-neuronal ND-75KD (F) adult brain tissue using Tub-Gal80ts; nSyb-Gal4. (G, H) Phospho-eIF2α (P- eIF2α, red) expression in control (G) or ND-75KD (H) larval motor neurons using OK371-Gal4. CD8-GFP (green) expression labels motor neurons. (I) Quantification of Phospho-eIF2α expression. Control n = 15, ND-75KD n = 14 larval CNS. Student’s t test. (J) Quantification of ATF4 expression. n = 12 larval CNS for all genotypes. 1 day old male and female flies were used in all panels. Data were analysed using ANOVA with Tukey’s posthoc test. Controls are OK371-Gal4 or Tub-Gal80ts; nSyb-Gal4 hemizygotes. Data are represented as mean ± SEM. n.s. not significant, *p<0.05, **p<0.01, ***p < 0.001.
To independently test the consequences of UPR activation in the nervous system we expressed dominant negative forms of the ER chaperone Hsc70-3 (GRP78, BiP), which ectopically activates the UPR [40]. Pan-neuronal expression of Hsc70-3D231S caused pupal lethality, while expression of Hsc70-3K97S caused a climbing defect (S3D Fig). This finding is consistent with the idea that activation of the UPR contributes to neuronal dysfunction in ND-75KD flies.
Transcriptional and metabolic disruption in ND-75KD flies
Mitochondrial stress signalling enables mitochondria to reprogramme nuclear gene expression, impacting a wide range of cellular functions [5]. To gain insight into the transcriptional changes induced by mitochondrial complex I deficiency in neurons we performed transcriptomic analysis of head tissue from ND-75KD flies. The expression of 1694 genes were significantly increased, and 2017 genes were significantly decreased in ND-75KD flies (S1 and S2 Tables), indicating a strong mitochondrial stress induced transcriptional response. Gene ontology (GO) analysis of genes with increased expression in ND-75KD flies showed significant enrichment of cellular components and molecular functions including transcriptional activity and ubiquitination (S3E and S3F Fig and S3 Table). However, apart from one of the two Drosophila orthologs of Hsp10 (CG9920) whose expression was increased (S1 Table), the expression of genes that respond to the mitochondrial unfolded response (UPRmt; Hsp60C, Hsc70-5 and Hsp10; [41]) were unchanged in ND-75KD flies, suggesting that the UPRmt is not activated. By contrast, consistent with activation of the UPR and ATF4 in ND-75KD neurons, 39 of the 230 high confidence Drosophila homologs of mammalian ATF4 target genes had significantly increased expression in ND-75KD flies, including the established ATF4 target protein phosphatase 1 regulatory subunit 15 (PPP1R15), or Gadd34, which mediates dephosphorylation of eIF2α (S1 and S5 Tables) [42]. The expression of several autophagy genes (including Atg1, Atg2, Atg5, Atg8a) were also increased in ND-75KD flies, suggesting induction of autophagy and/or mitophagy (S1 Table).
GO analysis of genes with reduced expression showed striking enrichment for mitochondrial genes (Fig 4A). Moreover, Kyoto encyclopaedia of genes and genomes (KEGG; [43]) pathway analysis of genes with reduced expression showed genes involved in oxidative phosphorylation and the TCA cycle as significantly enriched (Fig 4B). Strikingly, in addition to ND-75, the expression of 28 genes encoding core or accessory subunits of complex I, or complex I assembly factors were significantly decreased in ND-75KD fly head tissue (Fig 4C and S2 Table), while none were significantly increased (S1 Table). Furthermore, expression of multiple subunits of the other four mitochondrial respiratory complexes were significantly decreased by neuronal ND-75KD (Fig 4C and S2 Table). Moreover, the expression of genes encoding numerous antioxidant enzymes were significantly decreased in ND-75KD brain tissue (S2 Table). These data reveal a concerted transcriptional response to depress neuronal mitochondrial respiratory complex gene expression in the brain in response to complex I deficiency.
Fig 4. ND-75KD inhibits mitochondrial gene expression and disrupts the metabolism the brain.
(A) GO cellular component analysis of genes with significantly decreased expression in head tissue from pan-neuronal ND-75KD using Tub-Gal80ts; nSyb-Gal4. (B) KEGG pathway analysis of genes with significantly decreased expression in head tissue from pan-neuronal ND-75KD using Tub-Gal80ts; nSyb-Gal4. (C) Heatmap showing reduced expression of OXPHOS and TCA cycle genes in ND-75KD head tissue. (D) Principle component analysis of metabolite levels in head tissue from control, ND-75KD, NDI1 and ND-75KD, NDI1 expressing flies using Tub-Gal80ts; nSyb-Gal4. (E) MSEA analysis of significantly altered metabolites in head tissue from pan-neuronal ND-75KD using Tub-Gal80ts; nSyb-Gal4. (F) Heat map showing that a subset metabolites whose are significantly different in ND-75KD heat tissue are reversed by NDI1 expression. (G-I) Levels of adenine (G), fumarate (H) and GABA (I) control, ND-75KD, NDI1 and ND-75KD, NDI1 expressing flies from metabolomic analysis. n = 6 biological replicates for all genotypes. Controls are Tub-Gal80ts; nSyb-Gal4 hemizygotes. 2 day old male and female flies were used in all panels. Data are represented as mean ± SEM and were analysed using the Student’s t test. ns not significant, *p<0.05, **p<0.01, ***p < 0.001, ***p < 0.0001.
Genes encoding TCA cycle enzymes isocitrate dehydrogenase, succinyl-CoA synthetase, succinate dehydrogenase, fumarate hydratase, malate dehydrogenase, citrate synthase and components of the pyruvate dehydrogenase complex and oxoglutarate dehydrogenase complex were significantly decreased in ND-75KD head tissue (Fig 4C and S2 Table), whilst no TCA cycle genes were significantly increased (S1 Table), strongly implying that neuronal mitochondrial metabolism is perturbed by neuronal complex I deficiency. To investigate this further, we performed metabolomic analysis of head tissue to directly analyse the mitochondrial metabolic changes in the brain caused by complex I deficiency (S6 Table). Principle component analysis showed that the metabolite profile in ND-75KD fly heads was markedly different to controls (Fig 4D). Moreover, ND-75KD flies had a significant increase in the level of 22 metabolites, and a significant decrease in the level of 21 metabolites compared to controls (S7 Table). Metabolite set enrichment analysis (MSEA) showed significant dysregulation of a variety of KEGG pathways in ND-75KD head tissue including purine and amino acid metabolism, the TCA cycle and urea cycle (Fig 4E). Levels of the purine nucleotide adenine were significantly increased, and the TCA cycle intermediate fumarate were significantly decreased in ND-75KD heads (Fig 4F–4H and S7 Table). 2-hydroxyglutarate levels were strongly increased (Fig 4F and S7 Table), which we and others have shown is elevated in other mitochondrial dysfunction/disease models [9,44]. Glutamate and γ-aminobutyric acid (GABA) levels were also increased in ND-75KD fly heads (Fig 4I and S7 Table), indicating that neuronal complex I deficiency affects neurotransmitter levels. Collectively, these data demonstrate that complex I deficiency in neurons disrupts metabolism.
NDI1 expression partially reverses the neuronal metabolic disruption in ND-75KD flies
NADH oxidation by complex I replenishes NAD+, an essential coenzyme for the TCA cycle enzymes isocitrate dehydrogenase, α-ketoglutarate dehydrogenase and malate dehydrogenase. TCA cycle intermediates contribute to numerous biosynthetic pathways, including amino acid, fatty acid and purine/pyrimidine synthesis [45,46]. Disruption of the TCA cycle could thus lead to wide-ranging alterations in metabolism in ND-75KD flies. We therefore hypothesised that impaired complex I NADH dehydrogenase activity is a key driver of neuronal dysfunction in ND-75KD flies. To test this hypothesis, we utilised the Saccharomyces cerevisiae single-subunit non-proton translocating NADH dehydrogenase NDI1, which oxidises mitochondrial NADH and transfers electrons to ubiquinone but does not directly contribute to OXPHOS-mediated ATP production [47]. NDI1 expression should therefore restore TCA cycle activity in ND-75KD neurons deficient for complex I activity. We first confirmed that addition of the NDI1 transgene did not alter the strong reduction in ND-75 expression in ND-75KD flies with NDI1 expression (S1A Fig). Metabolomic analysis of heads from flies with pan-neuronal ND-75KD combined with NDI1 expression showed a dramatically altered metabolite profile compared to ND-75KD alone (Fig 4D). Expression of NDI1 reversed the 23 of 45 metabolites whose levels were aberrant in ND-75KD head tissue, including adenine and fumarate (Fig 4F–4I and S3 and S4 Tables). Interestingly, NDI1 expression also reversed the dramatic increase in GABA levels in ND-75KD flies (Fig 4F and 4I and S3 and S4 Tables). Thus, expression of NDI1 prevents many of the metabolic changes caused by knockdown of ND-75 in neurons, suggesting that restoration of mitochondrial NADH dehydrogenase activity broadly benefits neuronal metabolism in complex I deficiency.
NDI1 expression reinstates ER-mitochondria contacts, rescues neuronal dysfunction and death, and prevents UPR activation caused by complex I deficiency
As expected, expression of NDI1 restored the loss of NADH dehydrogenase activity in ND-75KD flies (Fig 5A). To test whether impaired NADH dehydrogenase-associated metabolic defects underlie the neuronal dysfunction caused by complex I deficiency, we next analysed the effects of NDI1 expression on motor function, seizure susceptibility and lifespan. NDI1 expression dramatically improved the climbing defect and completely prevented seizures in ND-75KD flies (Fig 5B and 5D). Moreover, ND-75KD flies expressing NDI1 had a median lifespan of 51 days, similar to controls (54 days; Fig 5E).
Fig 5. Neuronal NDI1 expression restores climbing ablility, prevents seizures and early death in ND-75KD flies.
(A) Complex I activity in mitochondria isolated from adult flies with ubiqitious NDI1 expression, ND-75KD, or ND-75KD with NDI1 using Da-GS-Gal4. n = 5 biological replicates for all genotypes. Control n = 6, NDI1 n = 4, n = ND-75KD n = 6, ND-75KD with NDI1 n = 3 biological replicates. (B) Quantification of climbing ability in control flies or with pan-neuronal expression of NDI1, ND-75KD, or ND-75KD with NDI1. n = 12 flies for all genotypes. (C, D) Quantification of seizure frequency (C) and duration (D) in control flies or with pan-neuronal expression of NDI1, ND-75KD, or ND-75KD with NDI1. Control n = 17, NDI1 n = 12, n = ND-75KD n = 48, ND-75KD with NDI1 n = 16 flies. (E) Lifespan analysis in control flies or with pan-neuronal expression of NDI1, ND-75KD, or ND-75KD with NDI1. ND-75 RNAi expressed using Tub-Gal80ts; nSyb-Gal4. Controls are Tub-Gal80ts; nSyb-Gal4 hemizygotes. Control n = 130, NDI1 n = 128, ND-75KD n = 127, ND-75KD; NDI1 n = 152. 5 day old male and female flies were used in (A). 1 day old male flies were used in (B) and 1 day old males and females in (C) and (D). Male flies were used in (E). Data are represented as mean ± SEM and were analysed using ANOVA with Tukey’s posthoc test, Chi-squared for seizure frequency, or log-rank test for survival curve. n.s not significant, ***p < 0.001.
Complex I is a major source of ROS and NDI1 has been shown to increase reverse electron transport-mediated ROS production at complex I through the enhancement of reverse electron transport [48]. We analysed ROS using a ratiometric fluorescent probe (mito-roGFP2-Grx1) to measure glutathione redox potential in neurons [49], which we have previously validated [29,50]. ND-75KD in neurons caused a decrease in probe oxidation (S4A, S4B, and S4E Fig), indicating reduced mitochondrial glutathione associated ROS. As expected, expression of NDI1 in neurons alone or in combination with ND-75 knockdown increased mitochondrial glutathione redox potential (S4A-S4E Fig). However, manipulation of ROS levels in ND-75KD flies through knock-down of Sod1, or Sod2, or overexpression of Sod2, catalase, or a mitochondrially targeted catalase, using previously validated transgenes [51], did not modify the climbing phenotype (S4F–S4J Fig). Therefore, although NDI expression elevates ROS levels, the severe behavioural phenotypes in ND-75 KD flies are unlikely to be the result of impaired ROS production.
Finally, following the observation that NDI1 expression rescues neuronal function in ND-75KD neurons, we investigated whether NDI1 expression ameliorates ND-75KD induced changes to mitochondrial morphology, ER-mitochondria contacts and activation of the UPR. Strikingly, we found that NDI1 expression rescued the mitochondrial number and morphology changes (Fig 6A–6F), the loss of ER-mitochondria contacts (Fig 6G–6K) and prevented ATF4 activation caused by ND-75 knockdown in neurons (Fig 6L–6P). Therefore, using NDI1 to at least partially reverse the metabolic disruption caused by ND-75 knockdown prevents UPR activation, neuronal dysfunction and early death in Drosophila.
Discussion
Neurons are highly energetically and metabolically demanding and so are acutely sensitive to mitochondrial dysfunction. We have dissected the cellular and molecular mechanisms underlying neuronal complex I deficiency in vivo using ND-75KD in Drosophila. Loss of complex I activity in neurons has profound effects on mitochondrial morphology and decreases ER-mitochondria contacts. Consistent with disruption of ER-mitochondria contacts, we find activation of the ER UPR and expression of ATF4 in ND-75KD neurons. ND-75KD causes transcriptional reprogramming, potentially as an attempt to mitigate the loss of complex I activity, repressing complex I and TCA cycle gene expression. There is also evidence of alterations in numerous metabolic pathways, beyond the mitochondrion, as a result of complex I deficiency. Expression of yeast NDI1 in ND-75KD flies reverses key metabolic changes, suggesting that restoring mitochondrial metabolism prevents UPR activation and neuronal dysfunction caused by complex I deficiency.
A previous Drosophila ND-75 knockdown model used a different ND-75 RNAi line, which results in much weaker phenotypes [13]. Using the same ubiquitous Gal4 driver (Da-Gal4) Hegde et al., found ND-75 knockdown resulted in adult flies with reduced lifespan, whereas we found that ubiquitous ND-75 knockdown caused developmental lethality. Moreover, Hegde et al., found neuronal specific ND-75 knockdown flies had a 25 day median lifespan, whereas our ND-75KD model has a median lifespan of 5 days. Although we have not directly compared the efficiency of the two RNAi lines, the differences are likely due to the highly efficient knockdown of ND-75 expression in our ND-75KD model.
ATP levels are unaffected by ND-75 knockdown either in individual neurons, or in ND-75KD fly whole head tissue. These findings contrast with a previous Drosophila mitochondrial disease model with a mutation in the mitochondrial-DNA-encoded NADH dehydrogenase subunit 2 (ND2) gene [52]. ND2 mutants have reduced ATP levels in heads from 35 day old flies, whereas ATP levels in young flies were not analysed. We analysed ATP levels in very young (2 day old) ND-75KD flies, at which time the brain may have more metabolic plasticity than in old flies. Consistent with this, metabolomic data show significantly increased lactate levels in ND-75KD head tissue (S2H Fig and S6 Table).
Understanding the basis of the neurological manifestations of complex I deficiency in patients is hampered by the complex interactions between neurons and glia and the systemic effects of changes to tissues and organs outside the nervous system. Our ND-75KD model provides cell autonomous insight into the effects of neuronal complex I deficiency in vivo. Neuronal ND-75KD causes mitochondrial morphology changes, similar to those caused by knockout of the mitochondrial transcription factor TFAM in dopaminergic neurons [53]. The dramatic reduction in expression of respiratory and TCA cycle genes caused by ND-75KD unbalances the expression of mitochondrial genes encoded by the nuclear and mitochondrial genomes. This disruption of inter-organelle gene expression may underlie the mitochondrial morphology defects in ND-75KD neurons. Interestingly, the master regulator of mitochondrial biogenesis PGC-1α is regulated by the NAD+-dependent deacetylase SIRT1 [54], providing a potential link between the loss of NADH dehydrogenase activity and mitochondrial biogenesis in ND-75KD neurons.
Modulation of mitochondrial morphology driven by Drp1 overexpression causes reduced ER-mitochondria contacts in mammalian cultured cells and primary neurons [30,31]. The reduced ER-mitochondria contacts in ND-75KD neurons are therefore also likely caused by the dramatic mitochondrial morphological changes. ER-mitochondria tethering proteins are involved in regulation of the ER UPR, and modification of ER-mitochondria tethers can trigger UPR activation [55,56]. Together with these studies, our data suggest that ER UPR activation is caused by reduced ER-mitochondrial contacts in ND-75KD neurons. Altered ER-mitochondria contacts are a common feature of neurodegenerative disease and there is strong evidence to suggest that they play a pivotal role in disease pathogenesis [56]. Restoring ER-mitochondria contacts may therefore also have therapeutic potential in complex I deficiency.
Our data show that ND-75KD activates ATF4 expression via the ER UPR in neurons. ER UPR activation likely contributes to the neurological defects in ND-75KD flies as ectopic ER UPR activation via expression of dominant negative forms of Hsc70-3 also causes neuronal dysfunction. Activation of the ER UPR and integrated stress response (ISR) are frequently observed in response to mitochondrial dysfunction [4,5,7]. We have previously shown ER UPR and ATF4 activation due to mitochondrial dysfunction in Drosophila neurons using a TFAM overexpression model [9]. Loss of Pink1, Parkin, DJ-1 or OXPHOS inhibition also cause ER UPR or ISR activation [8,36,57,58]. The direct cause of ER UPR and ISR activation in cells with dysfunctional mitochondria is much less well understood. Recently, screening approaches in cultured mammalian cells identified a novel OMA1-DELE1-HRI pathway that activates the ISR in response to mitochondrial dysfunction [59,60]. Whether this pathway is active in neurons is not known but Drosophila do not have an HRI kinase homolog, so this mechanism is unlikely to be relevant to stress signalling in Drosophila.
NDI1 expression has been shown to extend lifespan and rescue the lethality caused by ubiquitous complex I deficiency in Drosophila [61,62]. Viral expression of NDI1 into the substantia nigra protects against rotenone induced toxicity in a rat model of Parkinson’s disease [63]. In ageing models, NDI1 expression extends lifespan by increasing ROS through over reduction of the ubiquinone pool [48]. In the Ndufs4 knockout mouse model of Leigh syndrome, NDI1 expression rescues the lifespan but not motor defects, potentially through regenerating mitochondrial NAD+ from NADH [16]. ND-75 knockdown in neurons does not affect ATP levels but our metabolic analysis shows that complex I inhibition causes dramatic changes in metabolism, potentially due to aberrant NAD+/NADH inhibiting the TCA cycle leading to broad metabolic alterations. We identified a variety of metabolites whose altered levels in complex I deficiency are reversed by NDI1 expression, including the TCA cycle metabolite fumarate. Increased levels of the major inhibitory neurotransmitter GABA may also contribute to the behavioural phenotypes in ND-75KD flies. Interestingly, glutamate decarboxylase 1 (Gad1) expression is significantly increased by ND-75KD (S1 Table), suggesting that GABA levels may increase in part due to transcriptional mis-regulation. Overall, our study indicates that disruption of metabolism due to loss of NADH dehydrogenase activity is a driver of pathogenesis in the ND-75KD Drosophila model. The in-depth knowledge of the mechanisms contributing to neuronal complex I deficiency afforded by the Drosophila ND-75KD model may in future lead to therapeutic strategies tailored to combat the neurological manifestations in mitochondrial disease.
Materials and methods
Fly strains and growth conditions
Fly food consisted of 20g cornmeal (Dunn’s River), 100g Brewer’s yeast (MP biomedicals) and 8g Agar (Acros Organics) in 1L total volume of Milli-Q water. Ingredients were mixed and heated for 1.5 hours using a Systex Mediaprep machine. Once the mixture had cooled to 50°C, 25 ml 10% w/v Nipagin (Sigma) dissolved in 70% ethanol, and 5ml propionic acid (Acros Organics) were added. After an additional 2 minutes of mixing, the liquid food was poured into vials and left to solidify. To produce RU-486 containing food, 2ml of 100mM RU-486 was added and mixed into 1L of liquid fly food immediately before pouring. Flies were maintained at 25°C in a 12 hour light/dark cycle unless stated otherwise.
Details of fly stocks are listed in S8 Table. ND-75 RNAi lines were from the TRiP collection [64]. Fly stocks were obtained from the Bloomington Stock Center, the Vienna Drosophila Resource Center [65], the NIG-Fly Stock Center, Japan. For ubiquitous ND-75 knockdown using Daughterless-GeneSwitch-GAL4 [20], progeny were collected on the day of eclosion and kept at 29°C for 5 days, to maximise Gal4 activity, on food containing 200μM RU-486. Pan-neuronal ND-75 knockdown was performed using Tub-Gal80ts; nSyb-Gal4 at 25°C as ND-75 knockdown with nSyb-Gal4 causes late pupal lethality. For imaging experiments embryos were laid over a 24 hour period at 25°C, incubated for a further 24 hours at 25°C, then incubated at 29°C for three days prior to analysis, unless stated otherwise.
Generation of SPLICS transgenic flies
To generate SPLICS flies, the SPLICSL insertion was sub-cloned from a pcDNA3 backbone (gift from Tito Calí; [31]) into a pUASP vector as a BamHI-Xbal fragment. The pUASP-SPLICS construct was then integrated into the Drosophila genome by P-element mediated transposition. Embryo injections were performed by the Fly Facility of the Department of Genetics of the University of Cambridge.
Behavioural analysis
Climbing assays were performed using male flies as described previously [9].
For assays using flies with neuronal dysfunction vials were placed on their sides during eclosion to prevent flies from becoming stuck in the food. For open-field locomotor activity flies were anaesthetised using CO2 on the day of eclosion, and males of the desired genotype collected. Locomotor assays were performed the following morning, 1–4 hours after the start of the 12h light cycle. Flies were briefly anaesthetised on ice and placed into individual open-field arenas 35mm in diameter and 1.8mm in height with vibrating motors attached [66]. Flies were left to acclimatise to the arenas for 15 minutes prior to the start of video recording. Flies were video recorded for a total of 2 hours 15 minutes: after an initial rest period of 30 minutes, flies were subjected to a mechanical stimulus (5 vibrations, 0.2 seconds long, 0.5 seconds apart) followed by 15 minutes recovery. This pattern of stimulus and recovery was repeated a further 5 times before a final rest period of 15 minutes. Tracking of individual flies and analysis of average speed, total distance and immobility was performed using Anymaze software (Stoelting).
Mechanical stress-induced seizure assays were performed using both male and female flies. Flies of the desired genotype were collected on the day of eclosion and added to fresh vials so that each vial contained a total of 2 flies. The following day, flies were transferred to an empty vial, and vortexed at full speed for 10 seconds. Immediately after vortexing, flies were observed for seizures. The ‘bang-sensitive’ seizure phenotype triggered by mechanical stress is well defined [67]. A seizure was defined as a period of paralysis, potentially interspersed with limb twitching, wing movements and abdominal contractions. The length of each seizure was recorded, with the seizure considered to have ended when the fly stood upright. The experimenter was blinded to phenotype until data analysis had been completed.
Lifespan assays were performed using male flies. Male flies of the desired genotype were collected on the day of eclosion and added to fresh vials. 10 flies were initially added to each vial, and flies were incubated on their sides at 25°C for the duration of the assay. Every 2–3 days, flies were flipped into fresh vials and the number of dead flies in each vial were recorded. Dead flies that were carried over into the fresh vials were deducted from the next death count. Any flies that escaped during flipping, or were alive but stuck in the food so could not be flipped, were censored and deducted from the total fly count. Vials were flipped until all residing flies were dead.
To measure food intake, the CApillary FEeder assay (CAFE) was performed using 10 male and female flies per container for 24 hours as in [68].
qRT-PCR
qRT-PCR was performed as described previously [9]. The following primers were used:
ND-75 forward: 5’-ACATTAACTACACGGGCAAGC-3’
ND-75 reverse: 5’- CAATCTCGGAGGCGAAAC-3’
Rpl4 forward: 5’-TCCACCTTGAAGAAGGGCTA-3’
Rpl4 reverse: 5’-TTGCGGATCTCCTCAGACTT-3’
Mitochondrial NADH dehydrogenase (complex I) assay
Flies were snap-frozen in liquid nitrogen and stored at -70°C until required. For each replicate, 30 females and 30 males were used. Flies were first ground together using a Potter-Elvehjem type homogeniser at 700rpm for 12 passes, in 600μl extraction buffer. The extraction buffer consisted of 250mM sucrose, 5mM Tris (pH 7.4), 2mM EGTA (pH 8.0) and 1% bovine serum albumin (BSA) in ddH2O. The resulting homogenates next underwent a series of centrifugation steps at 4°C. Firstly, samples were spun at 1000g for 5 minutes. Supernatants were then taken and again spun at 1000g for 5 minutes. Supernatants were taken again and spun at 3000g for 10 minutes. Supernatants were then discarded, and 5ml extraction buffer was added to the remaining pellets. After another round of centrifugation at 3000g for 10 minutes, the supernatants were again discarded, and 5ml extraction buffer containing sucrose, Tris and EGTA only (no BSA), was added to the pellets. Samples were then spun for a final time at 7000g for 10 minutes. Supernatants were removed and pellets (mitochondrial fraction) were resuspended in 500 μl of extraction buffer without BSA. The concentration of mitochondria in resuspended pellets was determined using a Pierce bicinchoninic acid (BCA) assay (Thermo Fisher Scientific) following the manufacturer’s protocol.
Mitochondrial complex I and citrate synthase activity were assessed using a published protocol [69]. To disrupt mitochondrial membranes and maximise enzymatic readouts, isolated mitochondria underwent 3 freeze-thaw cycles prior to use.
For measurement of rotenone-sensitive complex I activity, 30μg/ml isolated mitochondria were added to a cuvette containing 100μl potassium phosphate buffer (0.5M, 0.5M potassium phosphate monobasic added to 0.5M potassium phosphate dibasic, pH 7.5), 60μl fatty acid-free BSA (50mg/ml), 30μl freshly prepared potassium cyanide (10mM) and 10μl freshly prepared NADH (10mM). A second, identical cuvette was prepared, with the addition of 10μl rotenone (1mM). Volumes were then adjusted to 994μl using ddH2O. After mixing, baseline absorbance was read for 2 minutes at 340nm and 25°C using a SPECTROstar Nano (BMG Labtech). After recording of the baseline, 6μl ubiquinone1 (10 mM) was added to cuvettes, and the change in absorbance (Δabsorbance) was immediately recorded for 2 minutes at 340nm and 25°C. To calculate the ubiquinone-dependent Δabsorbance, the baseline Δabsorbance was subtracted from Δabsorbance recorded after ubiquinone1 addition. The rotenone-sensitive Δabsorbance for each sample was then calculated by subtracting the Δabsorbance/minute with rotenone from the Δabsorbance/minute without rotenone. Rotenone-sensitive complex I activity was calculated using the following equation: enzyme activity (nmol/min/mg) = (Δabsorbance/min × 1,000)/[(extinction coefficient × volume of sample used in ml) × (sample protein concentration in mg/ml)], where the extinction co-efficient = 6.2 (NADH), volume = 1 and sample protein concentration = 0.03.
For measurement of citrate synthase activity, 5μg/ml isolated mitochondria were added to a cuvette containing 500μl Tris (200mM, pH 8.0) with 0.2% Triton X-100, 100μl freshly prepared 5,5-dithio-bis-(2-nitrobenzoic acid) (DNTB, 1mM) and 30μl acetyl CoA (10 mM). Volumes were then adjusted to 950μl using ddH2O. After mixing, baseline absorbance was read for 2 minutes at 412nm at 25°C using a SPECTROstar Nano (BMG Labtech). After recording of the baseline, 50μl freshly prepared oxaloacetic acid (10mM) was added to the sample, and the change in absorbance was recorded for 3 minutes at 412nm and 25°C. To calculate the oxaloacetic acid-dependent Δabsorbance, the baseline Δabsorbance was subtracted from Δabsorbance recorded after oxaloacetic acid addition. Citrate synthase activity was calculated using the same equation as for determining complex I activity, where the extinction co-efficient = 13.6 (TNB), volume = 1 and sample protein concentration = 0.005.
ATP luciferase assay
20 fly heads were used for each replicate. To obtain fly heads, flies were placed into a 15ml falcon tube and snap-frozen in liquid nitrogen, before being vortexed 3 times for 5 seconds each. The tube contents were then tipped onto paper over dry ice, and heads were collected into an Eppendorf using a cold paintbrush. Snap-frozen fly heads were mashed using a pestle in 200μl buffer consisting of 100mM Tris (pH 7.4) and 4mM EDTA (pH 8.0) in ddH2O. Ground fly heads were immediately heated at 95°C for 3 minutes and spun down at 14000g for 5 minutes. The resulting supernatant was then diluted either 1 in 50 or 1 in 2 in ddH2O. The ATP luciferase assay was performed using an ATP determination kit (A22066, Thermo Scientific), and following manufacturers protocols. Luminescence levels were read using a Clariostar monochromator microplate reader (BMG Labtech), and fly ATP levels were calculated from a standard curve produced using the ATP standards. Sample protein concentrations were determined using a Pierce BCA assay (Thermo Fisher Scientific), following manufacturer’s protocols.
Immunofluorescence and imaging
Images were taken using a Nikon A1R confocal microscope or a Nikon Vt-iSIM super resolution microscope with NIS Elements software.
Antibody fluorescence levels were quantified using ImageJ. For experiments measuring larval ATF4 or eIF2α-P expression levels, the cellular membrane marker CD8-GFP was used to identify cells to be quantified. Maximum intensity projections were then produced from Z-stacks of the dorsal side of the VNC. For quantification of ATF4 levels, 20 nuclei were identified in the green channel (based off of CD8-GFP expression), and circled using the ‘freehand selections’ tool. The mean fluorescence intensity of the nuclei selected was then recorded in the ATF4 expression channel (red channel). The same method was used to quantify eIF2 α-P levels, except cytoplasmic regions were circled instead of nuclei. Förster resonance energy transfer (FRET)–based ATP biosensor AT-NL [28] imaging and quantification was performed as described previously [29]. Primary antibodies were rat anti-ATF4 (1:200, [9]), were rabbit anti-P-eIF2α (1:500, anti-Phospho-eIF2α [Ser51], Cell Signaling Technology 9721). Secondary antibodies were goat anti-rabbit Alexa Fluor 546 (Invitrogen A11035), goat anti-rat Alexa Fluor 555 (Thermo Fisher A21434).
The number of SPLICS GFP puncta was quantified using NIS-Elements advanced research software (v5.01.00, Nikon). Images of larval VNCs were first cropped in the XY plane so that only whole neuromeres remained. Next, images were processed using the ‘General Analysis (GA3)’ tool. Within GA3, an analysis flow chart was set up to identify and quantify the number of bright 3D spots within the GFP channel. The same diameter, z-axis elongation and intensity thresholds were applied to all images. The number of GFP spots in the image was used as a measure of the number of contacts per neuromere.
A Vt-iSIM super resolution microscope (Nikon) was used to capture mitoGFP expression. Samples were first located on the slide using 20x magnification. Images were taken at 100x magnification and 1.5x zoom using an SR Apo TIRF 100x oil immersion lens (NA = 1.49). Z-stacks each 100nm in depth were taken of the dorsal side of the VNC. All Images taken were 1000 x 1440 pixels in size at a resolution of 43.29nm/pixel. Images were deconvolved within NIS-Elements software using a blind algorithm with 10 iterations. To quantify mitochondrial number and volume images were analysed using the Measurement tool in Volocity (v6.3.1, PerkinElmer). A region of interest (ROI) 1.6x1.6μM in height and width was placed within a cell, positioned so that in all Z-stacks, the ROI remained within the same cell and excluded the nucleus. For each condition, a total of 30 ROIs were analysed from across 6 images, with each ROI placed in a different cell.
Western blot analysis
For each biological replicate, 10 male and 10 female flies were used. Flies were first homogenised in 40μl 1X sample buffer using a pestle in a 1.5ml Eppendorf and spun down at 14000g for 5 minutes. The 1X sample buffer consisted of 50mM Tris-HCl pH 6.8, 10% v/v glycerol, 2% w/v SDS and 0.01% w/v bromophenol blue. 100mM dithiothreitol (DTT) was added and samples were boiled at 95°C for 5 minutes. Samples were stored at -20°C. Antibodies used were rabbit anti-VDAC (1:1000; ab14374, Abcam), mouse anti-Ndufs3 (1:500; ab14711, Abcam), rabbit anti-actin (1:5000; 4967, Cell Signalling Technology), anti-rabbit phospho-AMPK (Thr172; #2535, Cell Signalling Technology). Total protein staining was performed using the REVERT Total Protein Stain Kit (926–11010, LiCor).
RNA sequencing (RNA-Seq) transcriptomic analysis
20 snap frozen fly heads (10 male and 10 female, 2 days old) were used for each replicate and placed into 100 μL of lysis buffer + β-mercaptoethanol from the Absolutely RNA Microprep kit (Agilent Technologies). Each genotype was prepared in quadruplicate. RNA was extracted from using the Absolutely RNA Microprep kit according to the manufacturer’s protocol. The samples were sent on dry ice to Novogene Ltd. Sequencing libraries were generated using NEBNext Ultra TM RNA Library Prep Kit for Illumina (NEB, USA) following manufacturer’s recommendations. The clustering of the index-coded samples was performed on a cBot Cluster Generation System using PE Cluster Kit cBot-HS (Illumina) according to the manufacturer’s instructions. After cluster generation, the library preparations were sequenced on an Illumina platform and paired-end reads were generated. Raw data (raw reads) of FASTQ format were firstly processed through fastp. Paired-end clean reads were mapped to the Drosophila_melanogaster ensemble 102 genome using HISAT2 software. Featurecounts was used to count the read numbers mapped of each gene, then RPKM (Reads Per Kilobase of exon model per Million mapped reads) of each gene was calculated based on the length of the gene and reads count mapped to this gene [70]. Differential expression analysis between conditions was performed using DESeq2 R package [71]. P values were adjusted using the Benjamini and Hochberg’s approach for controlling the False Discovery Rate (FDR). Genes with an adjusted P value < 0.05 found by DESeq2 were assigned as differentially expressed. GO enrichment analysis of differentially expressed genes was implemented by the clusterProfiler R package [72], in which gene length bias was corrected. GO terms with corrected P value less than 0.05 were considered significantly enriched by differential expressed genes. The clusterProfiler R package was used to test the statistical enrichment of differential expression genes in KEGG pathways. The heatmap was generated using SRPlot (http://www.bioinformatics.com.cn/srplot). Drosophila homologs of mouse ATF4 target genes [42] were identified using the Drosophila RNAi Screening Center Integrative Ortholog Prediction Tool [73] and only homologs with a high rank were included. RNA-Seq data have been deposited in NCBI’s Gene Expression Omnibus [74] and are accessible through GEO Series accession number GSE214562 (https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc= GSE214562).
Metabolomic analysis
Twenty adult flies (10 males and 10 females, 2 days old) for each replicate were snap-frozen on liquid nitrogen in a 15 ml Falcon tube and then vortexed for 5 s five times to decapitate. Heads were then quickly separated and stored at −80°C. Soluble metabolites were extracted directly from snap-frozen samples using cold acetonitrile/water (80/20, vol/vol) at 1 μl per 50 μg of samples. Fly heads were disrupted for 15 s by ultrasonication (Branson Sonifier 250) followed by vortexing for 3 times (60 s / time, 1 min on ice in between each vortex). Homogenized samples were incubated at −80°C overnight to precipitate proteins and subsequently thawed, vortexed, and centrifuged at 18,000 × g for 30 min at 4°C to pellet the debris. The supernatants were transferred to new vials and analysed by HPLC and high-resolution mass spectrometry and tandem mass spectrometry (MS/MS) as described in [9]. Raw values were normalised to total ion count. Metabolomic data were analysed using MetaboAnalyst 5.0 [75]. Metabolites which were not detected in three or more replicates for at least one condition were excluded from analysis. For pairwise global metabolite analysis, individual metabolite concentrations were compared using multiple unpaired two-way t-tests, and p values were adjusted for the FDR using the Benjamini–Hochberg method for multiple-hypothesis testing [76]. FDR-adjusted p values <0.05 were considered statistically significant. Pairwise MSEA was performed using the ‘quantitative enrichment analysis (QEA)’ algorithm [77]. The overall metabolite profile (S4 Table) was used as the reference library. FDR-adjusted p-values≤0.05 were considered statistically significant. Using QEA, a p value and a Q statistic, a description of the correlation between compound concentration profiles and clinical outcomes, were generated for each metabolic pathway. The actual Q-statistic calculated for each pathway was divided by the expected Q-statistic to provide the ‘enrichment ratio’. FDR-adjusted p-values≤0.05 were considered statistically significant.
Transmission electron microscopy (TEM)
TEM of larval CNS tissue was performed as described previously [50]. Briefly, tissues from third instar wandering larvae were dissected and fixed in 0.1 M NaPO4, pH 7.4, 1% glutaraldehyde, and 4% formaldehyde, pH 7.3, overnight. Fixed larval preparations were washed 3× in 0.1 M NaPO4 before incubation in OsO4 (1% in 0.1 M NaPO4, 1% potassium ferrocyanide (w/v) in 0.1 M NaPO4; 2 h), dehydrated in an ethanol series, and embedded using Epon araldite resin. Sections were imaged using a transmission electron microscope (TECNAI 12 G2; FEI) with a camera (Soft Imaging Solutions MegaView; Olympus) and Tecnai user interface v2.1.8 and analySIS v3.2 (Soft Imaging Systems).
Two day old dissected adult fly brain samples were post-fixed with 1% (w/v) osmium tetroxide and 1% potassium ferrocyanide (w/v) in 0.1M sodium phosphate buffer (pH 7.4) for 1 hour before being washed and dehydrated through a graded acetone series. Samples were then infiltrated with increasing concentrations of SPURR epoxy resin/acetone mixture before being placed into 100% resin overnight with rotation. The following day, the samples were infiltrated further before embedding (with the dorsal face orientated toward the sectioning plane) and polymerised at 70°C for 24 hours.
Ultrathin sections (50-70nm) were prepared using a Leica UC7 ultramicrotome (Leica microsystems, Vienna), mounted on grids and contrasted using UranyLess (22409 Electron Microscopy Sciences, USA) and lead citrate (22410 Electron Microscopy Sciences, USA). Samples were examined on a JEOL JEM 1400 Flash (JEOL, Japan) transmission microscope operated at 80 kV and images were acquired with a JEOL Flash Camera.
Mitochondrial contacts were quantified in ImageJ (version 1.52). Mitochondria with ER contacts were identified by observing a 30nm or less distance between the mitochondria and ER. For positive contacts, mitochondria circumferences were measured and recorded. The length of the ER with a distance <30nm was also measured and then divided by the mitochondria circumference to calculate the proportion of the mitochondrial membrane in contact with the ER.
Statistical analyses
Continuous data are expressed as mean ± S.E.M unless stated otherwise. Non-continuous data are expressed as percentages unless stated otherwise. Excluding metabolomic data, all data were analysed using Prism 8 (GraphPad). Student’s unpaired two-way t-tests were used for pairwise comparisons of continuous data. An F-test was used to test for unequal variances, and where significant, Welch’s correction was applied to the t-test. A one-way ANOVA with Tukey’s post-hoc test was used for continuous data with multiple comparisons. Where variances were unequal, Welch’s ANOVA followed by Dunnett’s T3 multiple comparisons test was used. Chi-squared test and Fisher’s tests were used for non-continuous data, and were applied to the raw values rather than percentages. The log-rank test was used for lifespan data. For the NADH dehydrogenase activity assay data were normalised to the control and then transformed using log base 2. P values <0.05 were considered significant; * p<0.05, ** p<0.01, *** p<0.001, ****p<0.0001, n.s. non-significant. Experimental conditions where all values were equal to 0 were not included in statistical analysis.
Supporting information
(A) qRT-PCR analysis of ND-75 mRNA levels from adult flies with ubiqitious ND-75KD using Da-GS-Gal4. n = 8 biological replicates for all genotypes. (B) Complex I activity in mitochondria isolated from adult flies with ubiqitious ND-75KD using Da-GS-Gal4. Control n = 5, ND-75KD n = 5 biological replicates. (C) Western blot analysis of ND-30 expression in adult flies with ubiqitious ND-75KD using Da-GS-Gal4. (D, E) Quantification of ND-30 expression relative to actin (D) and the mitochondrial outer membrane protein VDAC (E). Control n = 3, ND-75KD n = 3 biological replicates. (F) Heterozygous ND-75 RNAi flies do not have a climbing phenotype. n = 11 for all genotypes. (H) (G) Ubiqitious ND-75KD using Da-GS-Gal4 causes a strong climbing phenotype. Control n = 11, ND-75KD n = 11. (H) Reduced climbing abilty of flies expressing an alternative ND-75 shRNA (HMS00854) in neurons with Tub-Gal80ts; nSyb-Gal4. Control n = 11, ND-75KD n = 11. Controls are Da-GS-Gal4 or Tub-Gal80ts; nSyb-Gal4 hemizygotes. 5 day old male and female flies were used in (A)-(E). 1 day old male flies were used in (F, H). 5 day old male flies were used in (G). Data are represented as mean ± SEM and were analysed using Student’s unpaired t-test. ns not significant, *p<0.05, ***p < 0.001, ****p < 0.0001.
(TIF)
(A-B”) Fluorescence emission of a control ATP insensitive probe (AT-RK) (A-A”) and the ATP-sensing AT-NL probe (B-B”) when excited at 405nm (CFP, cyan) and 488nm (FRET, yellow) in larval motor neurons using OK371-Gal4. (C) Quantification of CFP/FRET fluorescence. Control n = 5, ND-75KD n = 5 larval CNS. (D-E”) AT-NL fluorescence emission of control and ND-75KD larval motor neurons when excited at 405nm (CFP, cyan) and 488nm (FRET, yellow) using OK371-Gal4. AT-RK n = 9, AT-NL n = 11 larval CNS. (F) Quantification of CFP/FRET fluorescence in control and ND-75KD neurons. Control n = 11, ND-75KD n = 11 larval CNS. (G) ATP levels measured in whole heads from control flies or with with pan-neuronal ND-75KD using Tub-Gal80ts; nSyb-Gal4. Control n = 8, ND-75KD n = 8 biological replicates. (H)Lactate levels from metabolomic analysis of pan-neuronal ND-75KD using Tub-Gal80ts; nSyb-Gal4. Control n = 6, ND-75KD n = 6.. 2 day old male and female flies were used in (G) and (H). Controls are OK371-Gal4 or Tub-Gal80ts; nSyb-Gal4 hemizygotes. Student’s t test. Data are represented as mean ± SEM. ns not significant, *p < 0.05.
(TIF)
(A, B) Visualisation of ER-mitochondria contacts by SPLICS expression in larval motor neurons using OK371-Gal4 in control (A) and with IP3R knockdown (B). (C) Quantification of ER-mitochondria contacts. Control n = 6, IP3R n = 6 larval CNS. (D) Climbing ability of flies with Hsc70-3[K97S] and Hsc70-3[D231S] overexpression in neurons using nSyb-Gal4. Control n = 15, Hsc70-3K97S n = 15. Controls are OK371-Gal4 or nSyb-Gal4 hemizygotes. Data are represented as mean ± SEM and were analysed using Student’s t test. ***p < 0.001, ****p < 0.0001 (E, F) GO cellular component (E) and molecular function (F) analyses of genes with significantly increased expression in head tissue from pan-neuronal ND-75KD using Tub-Gal80ts; nSyb-Gal4.
(TIF)
(A-D) mito-roGFP2-Grx1 expression showing merge of 405nm excitation (blue) and 488nm excitation (green) emission fluorescence in control (A) and ND-75KD (B), NDI1 expression (C) and or ND-75KD with NDI1(D) larval motor neurons using OK371-Gal4. (E) Quantification of mito-roGFP2-Grx1 405nm and 488nm excitation fluorescence. n = 15 larval CNS for all genotypes. (F-J) Climbing ability of pan-neuronal ND-75KD, using Tub-Gal80ts; nSyb-Gal4, with: (F) SOD1 RNAi, control n = 25, SOD1 RNAi n = 24, ND-75KD n = 24, ND-75KD;SOD1 RNAi n = 22 flies. (G) SOD2 RNAi, control n = 21, SOD2 RNAi n = 21, ND-75KD n = 7, ND-75KD;SOD2 RNAi n = 7 flies. (H) SOD2 overexpression (o/e), control n = 25, SOD2 o/e n = 25, ND-75KD n = 5, ND-75KD;SOD2 o/e n = 5 flies. (I) catalase overexpression (o/e), control n = 27, catalase o/e n = 24, ND-75KD n = 11 ND-75KD; catalase o/e n = 7 flies. (J) mitocatalase overexpression (o/e), control n = 15, mitocatalase o/e n = 15, ND-75KD n = 3 ND-75KD; mitocatalase o/e n = 5 flies. Controls are OK371-Gal4 or Tub-Gal80ts; nSyb-Gal4 hemizygotes. 1 day old male flies were used in (G-J). Student’s t test. Data are represented as mean ± SEM. n.s. not significant, *p < 0.05, **p<0.01, ***p<0.001, ****p < 0.0001.
(TIF)
(XLSX)
In column N, complex I genes are highlighted in green, complex II genes highlighted in blue (also components of the TCA cycle), complex III genes highlighted in red, compex IV genes highlighted in yellow, complex V genes highlighted in gray. TCA cycle genes are highlighted in orange (except SdhA-D in blue).
(XLSX)
(XLSX)
(XLSX)
(XLSX)
Colour of metabolite ID stands for: black = identity confirmed by standard or MS2, red = cannot separate, orange = identity not confirmed.
(XLSX)
(XLSX)
(DOCX)
Acknowledgments
We are grateful to Rita Sousa-Nunes, Nazif Alic, Alex Whitworth and Darren Williams for fly stocks and the KCL Centre for Ultrastructural Imaging for technical assistance. Stocks obtained from the Bloomington Drosophila Stock Center (NIH P40OD018537) and the Vienna Drosophila Resource Center and FlyORF were used in this study. We are grateful to Ben Kottler for assistance with behavioural analyses, Sabrina Liu for help with climbing assays, Laura Raik for help with the feeding assay, Clare Steele-King of the York Imaging and Cytometry Facility for help with TEM, Peng Gao and the Robert H. Lurie Cancer Center Metabolomics Core at Northwestern University Feinberg School of Medicine for metabolomics analysis. We thank the Wohl Cellular Imaging Centre at King’s College London for help with light microscopy.
Data Availability
RNA-Seq data have been deposited in NCBI's Gene Expression Omnibus and are accessible through GEO Series accession number GSE214562 (https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc= GSE214562).
Funding Statement
This work was funded by Alzheimer’s Research UK (ARUK-IRG2017A-2) and the MRC (MR/V013130/1) to JMB; LG was supported by the UK Medical Research Council (MR/N013700/1) and King’s College London MRC Doctoral Training Partnership in Biomedical Sciences; STS and LFA were supported by a Motor Neurone Disease Association (UK) PhD studentship (Sweeney/Oct15/884-792) and a BBSRC project grant (BB/M002322/1) to STS; R.P.C was supported by a Northwestern University Pulmonary and Critical Care Department Cugell predoctoral fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
References
- 1.Fassone E, Rahman S. Complex I deficiency: clinical features, biochemistry and molecular genetics. J Med Genet. 2012;49(9):578–90. Epub 2012/09/14. doi: 10.1136/jmedgenet-2012-101159 . [DOI] [PubMed] [Google Scholar]
- 2.Lake NJ, Compton AG, Rahman S, Thorburn DR. Leigh syndrome: One disorder, more than 75 monogenic causes. Annals of neurology. 2016;79(2):190–203. Epub 2015/10/28. doi: 10.1002/ana.24551 . [DOI] [PubMed] [Google Scholar]
- 3.Quintana A, Kruse SE, Kapur RP, Sanz E, Palmiter RD. Complex I deficiency due to loss of Ndufs4 in the brain results in progressive encephalopathy resembling Leigh syndrome. Proc Natl Acad Sci U S A. 2010;107(24):10996–1001. Epub 2010/06/11. doi: 10.1073/pnas.1006214107 ; PubMed Central PMCID: PMC2890717. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Hunt RJ, Bateman JM. Mitochondrial retrograde signaling in the nervous system. FEBS Lett. 2018;592(5):663–78. Epub 2017/11/01. doi: 10.1002/1873-3468.12890 . [DOI] [PubMed] [Google Scholar]
- 5.Granat L, Hunt RJ, Bateman JM. Mitochondrial retrograde signalling in neurological disease. Philos Trans R Soc Lond B Biol Sci. 2020;375(1801):20190415. Epub 2020/05/05. doi: 10.1098/rstb.2019.0415 ; PubMed Central PMCID: PMC7209953. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Chandel NS. Mitochondria as signaling organelles. BMC biology. 2014;12:34. Epub 2014/06/03. doi: 10.1186/1741-7007-12-34 ; PubMed Central PMCID: PMC4035690. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Quiros PM, Mottis A, Auwerx J. Mitonuclear communication in homeostasis and stress. Nature reviews Molecular cell biology. 2016;17(4):213–26. Epub 2016/03/10. doi: 10.1038/nrm.2016.23 . [DOI] [PubMed] [Google Scholar]
- 8.Quiros PM, Prado MA, Zamboni N, D’Amico D, Williams RW, Finley D, et al. Multi-omics analysis identifies ATF4 as a key regulator of the mitochondrial stress response in mammals. J Cell Biol. 2017;216(7):2027–45. Epub 2017/06/02. doi: 10.1083/jcb.201702058 ; PubMed Central PMCID: PMC5496626. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Hunt RJ, Granat L, McElroy GS, Ranganathan R, Chandel NS, Bateman JM. Mitochondrial stress causes neuronal dysfunction via an ATF4-dependent increase in L-2-hydroxyglutarate. J Cell Biol. 2019;218(12):4007–16. Epub 2019/10/28. doi: 10.1083/jcb.201904148 ; PubMed Central PMCID: PMC6891100. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.D’Amico D, Sorrentino V, Auwerx J. Cytosolic Proteostasis Networks of the Mitochondrial Stress Response. Trends in biochemical sciences. 2017;42(9):712–25. Epub 2017/06/06. doi: 10.1016/j.tibs.2017.05.002 . [DOI] [PubMed] [Google Scholar]
- 11.Hughes D, Mallucci GR. The unfolded protein response in neurodegenerative disorders—therapeutic modulation of the PERK pathway. The FEBS journal. 2019;286(2):342–55. Epub 2018/02/25. doi: 10.1111/febs.14422 . [DOI] [PubMed] [Google Scholar]
- 12.Burman JL, Itsara LS, Kayser E-B, Suthammarak W, Wang AM, Kaeberlein M, et al. A Drosophila model of mitochondrial disease caused by a complex I mutation that uncouples proton pumping from electron transfer. Disease models & mechanisms. 2014;7(10):1165–74. Epub 2014/08/01. doi: 10.1242/dmm.015321 . [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Hegde VR, Vogel R, Feany MB. Glia are critical for the neuropathology of complex I deficiency in Drosophila. Hum Mol Genet. 2014;23(17):4686–92. Epub 2014/04/25. doi: 10.1093/hmg/ddu188 ; PubMed Central PMCID: PMC4119418. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Kruse SE, Watt WC, Marcinek DJ, Kapur RP, Schenkman KA, Palmiter RD. Mice with mitochondrial complex I deficiency develop a fatal encephalomyopathy. Cell Metab. 2008;7(4):312–20. Epub 2008/04/09. doi: 10.1016/j.cmet.2008.02.004 ; PubMed Central PMCID: PMC2593686. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Loewen CA, Ganetzky B. Mito-Nuclear Interactions Affecting Lifespan and Neurodegeneration in a Drosophila Model of Leigh Syndrome. Genetics. 2018;208(4):1535–52. doi: 10.1534/genetics.118.300818 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.McElroy GS, Reczek CR, Reyfman PA, Mithal DS, Horbinski CM, Chandel NS. NAD+ Regeneration Rescues Lifespan, but Not Ataxia, in a Mouse Model of Brain Mitochondrial Complex I Dysfunction. Cell Metab. 2020;32(2):301–8.e6. Epub 2020/06/24. doi: 10.1016/j.cmet.2020.06.003 ; PubMed Central PMCID: PMC7415718. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Koene S, Rodenburg RJ, van der Knaap MS, Willemsen MAAP, Sperl W, Laugel V, et al. Natural disease course and genotype-phenotype correlations in Complex I deficiency caused by nuclear gene defects: what we learned from 130 cases. Journal of inherited metabolic disease. 2012;35(5):737–47. Epub 2012/05/30. doi: 10.1007/s10545-012-9492-z . [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Wirth C, Brandt U, Hunte C, Zickermann V. Structure and function of mitochondrial complex I. Biochimica et Biophysica Acta (BBA)—Bioenergetics. 2016;1857(7):902–14. doi: 10.1016/j.bbabio.2016.02.013 [DOI] [PubMed] [Google Scholar]
- 19.Toshniwal AG, Gupta S, Mandal L, Mandal S. ROS Inhibits Cell Growth by Regulating 4EBP and S6K, Independent of TOR, during Development. Dev Cell. 2019;49(3):473–89.e9. Epub 2019/05/08. doi: 10.1016/j.devcel.2019.04.008 . [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Osterwalder T, Yoon KS, White BH, Keshishian H. A conditional tissue-specific transgene expression system using inducible GAL4. Proc Natl Acad Sci U S A. 2001;98(22):12596–601. doi: 10.1073/pnas.221303298 ; PubMed Central PMCID: PMC60099. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Garcia CJ, Khajeh J, Coulanges E, Chen EIJ, Owusu-Ansah E. Regulation of Mitochondrial Complex I Biogenesis in Drosophila Flight Muscles. Cell reports. 2017;20(1):264–78. doi: 10.1016/j.celrep.2017.06.015 . [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Leigh Finsterer J. and Leigh-Like Syndrome in Children and Adults. Pediatric neurology. 2008;39(4):223–35. doi: 10.1016/j.pediatrneurol.2008.07.013 [DOI] [PubMed] [Google Scholar]
- 23.Finsterer J, Zarrouk Mahjoub S. Epilepsy in mitochondrial disorders. Seizure. 2012;21(5):316–21. Epub 2012/03/31. doi: 10.1016/j.seizure.2012.03.003 . [DOI] [PubMed] [Google Scholar]
- 24.Sofou K, De Coo IF, Isohanni P, Ostergaard E, Naess K, De Meirleir L, et al. A multicenter study on Leigh syndrome: disease course and predictors of survival. Orphanet journal of rare diseases. 2014;9:52. Epub 2014/04/16. doi: 10.1186/1750-1172-9-52 ; PubMed Central PMCID: PMC4021638. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Bjorkman K, Sofou K, Darin N, Holme E, Kollberg G, Asin-Cayuela J, et al. Broad phenotypic variability in patients with complex I deficiency due to mutations in NDUFS1 and NDUFV1. Mitochondrion. 2015;21:33–40. Epub 2015/01/24. doi: 10.1016/j.mito.2015.01.003 . [DOI] [PubMed] [Google Scholar]
- 26.Koopman WJ, Visch HJ, Verkaart S, van den Heuvel LW, Smeitink JA, Willems PH. Mitochondrial network complexity and pathological decrease in complex I activity are tightly correlated in isolated human complex I deficiency. American journal of physiology Cell physiology. 2005;289(4):C881–90. Epub 2005/05/20. doi: 10.1152/ajpcell.00104.2005 . [DOI] [PubMed] [Google Scholar]
- 27.Koopman WJ, Verkaart S, Visch HJ, van Emst-de Vries S, Nijtmans LG, Smeitink JA, et al. Human NADH:ubiquinone oxidoreductase deficiency: radical changes in mitochondrial morphology? American journal of physiology Cell physiology. 2007;293(1):C22–9. Epub 2007/04/13. doi: 10.1152/ajpcell.00194.2006 . [DOI] [PubMed] [Google Scholar]
- 28.Tsuyama T, Tsubouchi A, Usui T. Mitochondrial dysfunction induces dendritic loss via eIF2alpha phosphorylation. Journal of Cell Biology. 2017;216(3):815–34. doi: 10.1083/jcb.201604065 . [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Duncan OF, Granat L, Ranganathan R, Singh VK, Mazaud D, Fanto M, et al. Ras-ERK-ETS inhibition alleviates neuronal mitochondrial dysfunction by reprogramming mitochondrial retrograde signaling. PLoS Genet. 2018;14(7):e1007567. Epub 2018/07/31. doi: 10.1371/journal.pgen.1007567 ; PubMed Central PMCID: PMC6085068. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Cherubini M, Lopez-Molina L, Gines S. Mitochondrial fission in Huntington’s disease mouse striatum disrupts ER-mitochondria contacts leading to disturbances in Ca(2+) efflux and Reactive Oxygen Species (ROS) homeostasis. Neurobiol Dis. 2020;136:104741. Epub 2020/01/14. doi: 10.1016/j.nbd.2020.104741 . [DOI] [PubMed] [Google Scholar]
- 31.Cieri D, Vicario M, Giacomello M, Vallese F, Filadi R, Wagner T, et al. SPLICS: a split green fluorescent protein-based contact site sensor for narrow and wide heterotypic organelle juxtaposition. Cell Death & Differentiation. 2018;25(6):1131–45. doi: 10.1038/s41418-017-0033-z [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Rizzuto R, Pinton P, Carrington W, Fay FS, Fogarty KE, Lifshitz LM, et al. Close Contacts with the Endoplasmic Reticulum as Determinants of Mitochondrial Ca2+ Responses. Science. 1998;280(5370):1763. doi: 10.1126/science.280.5370.1763 [DOI] [PubMed] [Google Scholar]
- 33.Stoica R, De Vos KJ, Paillusson S, Mueller S, Sancho RM, Lau KF, et al. ER-mitochondria associations are regulated by the VAPB-PTPIP51 interaction and are disrupted by ALS/FTD-associated TDP-43. Nature communications. 2014;5:3996. Epub 2014/06/04. doi: 10.1038/ncomms4996 ; PubMed Central PMCID: PMC4046113. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Csordás G, Renken C, Várnai P, Walter L, Weaver D, Buttle KF, et al. Structural and functional features and significance of the physical linkage between ER and mitochondria. J Cell Biol. 2006;174(7):915–21. Epub 2006/09/20. doi: 10.1083/jcb.200604016 ; PubMed Central PMCID: PMC2064383. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Lee KS, Huh S, Lee S, Wu Z, Kim AK, Kang HY, et al. Altered ER-mitochondria contact impacts mitochondria calcium homeostasis and contributes to neurodegeneration in vivo in disease models. Proc Natl Acad Sci U S A. 2018;115(38):E8844–e53. Epub 2018/09/07. doi: 10.1073/pnas.1721136115 ; PubMed Central PMCID: PMC6156612. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Celardo I, Costa AC, Lehmann S, Jones C, Wood N, Mencacci NE, et al. Mitofusin-mediated ER stress triggers neurodegeneration in pink1/parkin models of Parkinson’s disease. Cell Death Dis. 2016;7(6):e2271. Epub 2016/06/24. doi: 10.1038/cddis.2016.173 ; PubMed Central PMCID: PMC5143399. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Lee S, Lee K-S, Huh S, Liu S, Lee D-Y, Hong Seung H, et al. Polo Kinase Phosphorylates Miro to Control ER-Mitochondria Contact Sites and Mitochondrial Ca2+ Homeostasis in Neural Stem Cell Development. Developmental Cell. 2016;37(2):174–89. doi: 10.1016/j.devcel.2016.03.023 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.De Vos KJ, Mórotz GM, Stoica R, Tudor EL, Lau KF, Ackerley S, et al. VAPB interacts with the mitochondrial protein PTPIP51 to regulate calcium homeostasis. Hum Mol Genet. 2012;21(6):1299–311. Epub 2011/12/02. doi: 10.1093/hmg/ddr559 ; PubMed Central PMCID: PMC3284118. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Hetz C, Mollereau B. Disturbance of endoplasmic reticulum proteostasis in neurodegenerative diseases. Nature reviews Neuroscience. 2014;15(4):233–49. Epub 2014/03/13. doi: 10.1038/nrn3689 . [DOI] [PubMed] [Google Scholar]
- 40.Elefant F, Palter KB. Tissue-specific expression of dominant negative mutant Drosophila HSC70 causes developmental defects and lethality. Mol Biol Cell. 1999;10(7):2101–17. Epub 1999/07/09. doi: 10.1091/mbc.10.7.2101 ; PubMed Central PMCID: PMC25422. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Owusu-Ansah E, Song W, Perrimon N. Muscle mitohormesis promotes longevity via systemic repression of insulin signaling. Cell. 2013;155(3):699–712. Epub 2013/11/19. doi: 10.1016/j.cell.2013.09.021 ; PubMed Central PMCID: PMC3856681. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Han J, Back SH, Hur J, Lin YH, Gildersleeve R, Shan J, et al. ER-stress-induced transcriptional regulation increases protein synthesis leading to cell death. Nat Cell Biol. 2013;15(5):481–90. Epub 20130428. doi: 10.1038/ncb2738 ; PubMed Central PMCID: PMC3692270. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Ogata H, Goto S, Sato K, Fujibuchi W, Bono H, Kanehisa M. KEGG: Kyoto Encyclopedia of Genes and Genomes. Nucleic Acids Res. 1999;27(1):29–34. Epub 1998/12/10. doi: 10.1093/nar/27.1.29 ; PubMed Central PMCID: PMC148090. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Burr SP, Costa AS, Grice GL, Timms RT, Lobb IT, Freisinger P, et al. Mitochondrial Protein Lipoylation and the 2-Oxoglutarate Dehydrogenase Complex Controls HIF1alpha Stability in Aerobic Conditions. Cell Metab. 2016;24(5):740–52. Epub 2016/12/08. doi: 10.1016/j.cmet.2016.09.015 ; PubMed Central PMCID: PMC5106373. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.Lane AN, Fan TWM. Regulation of mammalian nucleotide metabolism and biosynthesis. Nucleic acids research. 2015;43(4):2466–85. Epub 2015/01/27. doi: 10.1093/nar/gkv047 . [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46.Spinelli JB, Haigis MC. The multifaceted contributions of mitochondria to cellular metabolism. Nat Cell Biol. 2018;20(7):745–54. Epub 2018/06/29. doi: 10.1038/s41556-018-0124-1 . [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47.Seo BB, Kitajima-Ihara T, Chan EK, Scheffler IE, Matsuno-Yagi A, Yagi T. Molecular remedy of complex I defects: rotenone-insensitive internal NADH-quinone oxidoreductase of Saccharomyces cerevisiae mitochondria restores the NADH oxidase activity of complex I-deficient mammalian cells. Proc Natl Acad Sci U S A. 1998;95(16):9167–71. Epub 1998/08/05. doi: 10.1073/pnas.95.16.9167 ; PubMed Central PMCID: PMC21310. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.Scialò F, Fernández-Ayala DJ, Sanz A. Role of Mitochondrial Reverse Electron Transport in ROS Signaling: Potential Roles in Health and Disease. Frontiers in physiology. 2017;8:428–. doi: 10.3389/fphys.2017.00428 . [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49.Albrecht SC, Barata AG, Grosshans J, Teleman AA, Dick TP. In vivo mapping of hydrogen peroxide and oxidized glutathione reveals chemical and regional specificity of redox homeostasis. Cell Metab. 2011;14(6):819–29. doi: 10.1016/j.cmet.2011.10.010 . [DOI] [PubMed] [Google Scholar]
- 50.Cagin U, Duncan OF, Gatt AP, Dionne MS, Sweeney ST, Bateman JM. Mitochondrial retrograde signaling regulates neuronal function. Proc Natl Acad Sci U S A. 2015;112(44):E6000–9. Epub 2015/10/23. doi: 10.1073/pnas.1505036112 . [DOI] [PMC free article] [PubMed] [Google Scholar]
- 51.Oswald MC, Brooks PS, Zwart MF, Mukherjee A, West RJ, Giachello CN, et al. Reactive oxygen species regulate activity-dependent neuronal plasticity in Drosophila. eLife. 2018;7. Epub 2018/12/13. doi: 10.7554/eLife.39393 ; PubMed Central PMCID: PMC6307858. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52.Burman JL, Itsara LS, Kayser EB, Suthammarak W, Wang AM, Kaeberlein M, et al. A Drosophila model of mitochondrial disease caused by a complex I mutation that uncouples proton pumping from electron transfer. Disease models & mechanisms. 2014;7(10):1165–74. Epub 20140801. doi: 10.1242/dmm.015321 ; PubMed Central PMCID: PMC4174527. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 53.Sterky FH, Lee S, Wibom R, Olson L, Larsson NG. Impaired mitochondrial transport and Parkin-independent degeneration of respiratory chain-deficient dopamine neurons in vivo. Proc Natl Acad Sci U S A. 2011;108(31):12937–42. Epub 2011/07/20. 1103295108 [pii] doi: 10.1073/pnas.1103295108 ; PubMed Central PMCID: PMC3150929. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 54.Feige JN, Auwerx J. Transcriptional coregulators in the control of energy homeostasis. Trends Cell Biol. 2007;17(6):292–301. Epub 2007/05/04. doi: 10.1016/j.tcb.2007.04.001 . [DOI] [PubMed] [Google Scholar]
- 55.Chu Q, Martinez TF, Novak SW, Donaldson CJ, Tan D, Vaughan JM, et al. Regulation of the ER stress response by a mitochondrial microprotein. Nature communications. 2019;10(1):4883. Epub 2019/10/28. doi: 10.1038/s41467-019-12816-z ; PubMed Central PMCID: PMC6814811. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 56.Paillusson S, Stoica R, Gomez-Suaga P, Lau DH, Mueller S, Miller T, et al. There’s Something Wrong with my MAM; the ER-Mitochondria Axis and Neurodegenerative Diseases. Trends Neurosci. 2016;39(3):146–57. Epub 2016/02/24. doi: 10.1016/j.tins.2016.01.008 ; PubMed Central PMCID: PMC4780428. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 57.Khan NA, Nikkanen J, Yatsuga S, Jackson C, Wang L, Pradhan S, et al. mTORC1 Regulates Mitochondrial Integrated Stress Response and Mitochondrial Myopathy Progression. Cell Metab. 2017;26(2):419–28.e5. Epub 2017/08/03. doi: 10.1016/j.cmet.2017.07.007 . [DOI] [PubMed] [Google Scholar]
- 58.Yang J, Kim KS, Iyirhiaro GO, Marcogliese PC, Callaghan SM, Qu D, et al. DJ-1 modulates the unfolded protein response and cell death via upregulation of ATF4 following ER stress. Cell Death Dis. 2019;10(2):135. Epub 2019/02/14. doi: 10.1038/s41419-019-1354-2 ; PubMed Central PMCID: PMC6372623. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 59.Fessler E, Eckl EM, Schmitt S, Mancilla IA, Meyer-Bender MF, Hanf M, et al. A pathway coordinated by DELE1 relays mitochondrial stress to the cytosol. Nature. 2020;579(7799):433–7. Epub 2020/03/07. doi: 10.1038/s41586-020-2076-4 ; PubMed Central PMCID: PMC7116715. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 60.Guo X, Aviles G, Liu Y, Tian R, Unger BA, Lin YT, et al. Mitochondrial stress is relayed to the cytosol by an OMA1-DELE1-HRI pathway. Nature. 2020;579(7799):427–32. Epub 2020/03/07. doi: 10.1038/s41586-020-2078-2 ; PubMed Central PMCID: PMC7147832. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 61.Sanz A, Soikkeli M, Portero-Otin M, Wilson A, Kemppainen E, McIlroy G, et al. Expression of the yeast NADH dehydrogenase Ndi1 in Drosophila confers increased lifespan independently of dietary restriction. Proc Natl Acad Sci U S A. 2010;107(20):9105–10. Epub 2010/05/04. doi: 10.1073/pnas.0911539107 [pii] ; PubMed Central PMCID: PMC2889079. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 62.Bahadorani S, Cho J, Lo T, Contreras H, Lawal HO, Krantz DE, et al. Neuronal expression of a single-subunit yeast NADH-ubiquinone oxidoreductase (Ndi1) extends Drosophila lifespan. Aging Cell. 2010;9(2):191–202. Epub 2010/01/22. ACE546 [pii] doi: 10.1111/j.1474-9726.2010.00546.x ; PubMed Central PMCID: PMC2860002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 63.Marella M, Seo BB, Nakamaru-Ogiso E, Greenamyre JT, Matsuno-Yagi A, Yagi T. Protection by the NDI1 gene against neurodegeneration in a rotenone rat model of Parkinson’s disease. PloS one. 2008;3(1):e1433. doi: 10.1371/journal.pone.0001433 ; PubMed Central PMCID: PMC2175531. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 64.Perkins LA, Holderbaum L, Tao R, Hu Y, Sopko R, McCall K, et al. The Transgenic RNAi Project at Harvard Medical School: Resources and Validation. Genetics. 2015;201(3):843–52. Epub 20150828. doi: 10.1534/genetics.115.180208 ; PubMed Central PMCID: PMC4649654. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 65.Dietzl G, Chen D, Schnorrer F, Su KC, Barinova Y, Fellner M, et al. A genome-wide transgenic RNAi library for conditional gene inactivation in Drosophila. Nature. 2007;448(7150):151–6. Epub 2007/07/13. doi: 10.1038/nature05954 [pii] . [DOI] [PubMed] [Google Scholar]
- 66.Kottler B, Faville R, Bridi JC, Hirth F. Inverse Control of Turning Behavior by Dopamine D1 Receptor Signaling in Columnar and Ring Neurons of the Central Complex in Drosophila. Curr Biol. 2019;29(4):567–77.e6. Epub 2019/02/05. doi: 10.1016/j.cub.2019.01.017 ; PubMed Central PMCID: PMC6384123. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 67.Parker L, Howlett IC, Rusan ZM, Tanouye MA. Seizure and epilepsy: studies of seizure disorders in Drosophila. International review of neurobiology. 2011;99:1–21. Epub 2011/09/13. doi: 10.1016/B978-0-12-387003-2.00001-X ; PubMed Central PMCID: PMC3532860. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 68.Diegelmann S, Jansen A, Jois S, Kastenholz K, Velo Escarcena L, Strudthoff N, et al. The CApillary FEeder Assay Measures Food Intake in Drosophila melanogaster. J Vis Exp. 2017;(121). Epub 20170317. doi: 10.3791/55024 ; PubMed Central PMCID: PMC5408587. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 69.Spinazzi M, Casarin A, Pertegato V, Salviati L, Angelini C. Assessment of mitochondrial respiratory chain enzymatic activities on tissues and cultured cells. Nature Protocols. 2012;7(6):1235–46. doi: 10.1038/nprot.2012.058 [DOI] [PubMed] [Google Scholar]
- 70.Trapnell C, Williams BA, Pertea G, Mortazavi A, Kwan G, van Baren MJ, et al. Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation. Nature biotechnology. 2010;28(5):511–5. Epub 2010/05/04. doi: 10.1038/nbt.1621 ; PubMed Central PMCID: PMC3146043. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 71.Anders S, Huber W. Differential expression analysis for sequence count data. Genome Biol. 2010;11(10):R106. Epub 2010/10/29. doi: 10.1186/gb-2010-11-10-r106 ; PubMed Central PMCID: PMC3218662. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 72.Yu G, Wang LG, Han Y, He QY. clusterProfiler: an R package for comparing biological themes among gene clusters. Omics: a journal of integrative biology. 2012;16(5):284–7. Epub 2012/03/30. doi: 10.1089/omi.2011.0118 ; PubMed Central PMCID: PMC3339379. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 73.Hu Y, Flockhart I, Vinayagam A, Bergwitz C, Berger B, Perrimon N, et al. An integrative approach to ortholog prediction for disease-focused and other functional studies. BMC Bioinformatics. 2011;12:357. Epub 20110831. doi: 10.1186/1471-2105-12-357 ; PubMed Central PMCID: PMC3179972. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 74.Edgar R, Domrachev M, Lash AE. Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res. 2002;30(1):207–10. doi: 10.1093/nar/30.1.207 ; PubMed Central PMCID: PMC99122. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 75.Chong J, Soufan O, Li C, Caraus I, Li S, Bourque G, et al. MetaboAnalyst 4.0: towards more transparent and integrative metabolomics analysis. Nucleic acids research. 2018;46(W1):W486–W94. doi: 10.1093/nar/gky310 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 76.Benjamini Y, Hochberg Y. Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing. Journal of the Royal Statistical Society: Series B (Methodological). 1995;57(1):289–300. doi: 10.1111/j.2517-6161.1995.tb02031.x [DOI] [Google Scholar]
- 77.Xia J, Wishart DS. MSEA: a web-based tool to identify biologically meaningful patterns in quantitative metabolomic data. Nucleic Acids Res. 2010;38(Web Server issue):W71–7. Epub 2010/05/12. doi: 10.1093/nar/gkq329 ; PubMed Central PMCID: PMC2896187. [DOI] [PMC free article] [PubMed] [Google Scholar]